SH2D1A Antikörper (AA 1-128)
Kurzübersicht für SH2D1A Antikörper (AA 1-128) (ABIN1982328)
Target
Alle SH2D1A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-128
-
Produktmerkmale
- Polyclonal Sheep anti Human SH2D1A
-
Immunogen
- AA 1-128
-
Isotyp
- IgG
-
-
anti-SH2 Domain Containing 1A (SH2D1A) (AA 1-128) antibody
SH2D1A Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1C9 unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (AA 1-128) antibodySH2D1A Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (AA 11-124) antibodySH2D1A Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (AA 85-114), (C-Term) antibodySH2D1A Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41923 unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (C-Term) antibodySH2D1A Reaktivität: Human, Affe, Kaninchen, Fledermaus WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (AA 18-115) antibodySH2D1A Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (Internal Region) antibodyVerified SH2D1A Reaktivität: Human WB, ELISA, IP Wirt: Ziege Polyclonal unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (AA 1-128) antibodySH2D1A Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-SH2 Domain Containing 1A (SH2D1A) (C-Term) antibodySH2D1A Reaktivität: Human, Ratte, Rind (Kuh), Schwein, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal dilutions should be determined by each laboratory for each application.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 100 µL of PBS, pH 7.4
-
Konzentration
- 500 µg/mL
-
Buffer
- Lyophilized from a solution containing PBS, pH 7.4
-
Lagerung
- -20 °C
-
-
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
-
Andere Bezeichnung
- SH2D1A
-
UniProt
- O60880
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-
